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Abstract
Instrumental variable analysis is an approach for obtaining causal inferences on the effect of an exposure
(risk factor) on an outcome from observational data. It has gained in popularity over the past decade with
the use of genetic variants as instrumental variables, known as Mendelian randomization. An instrumental
variable is associated with the exposure, but not associated with any confounder of the exposure–
outcome association, nor is there any causal pathway from the instrumental variable to the outcome
other than via the exposure. Under the assumption that a single instrumental variable or a set of
instrumental variables for the exposure is available, the causal effect of the exposure on the outcome
can be estimated. There are several methods available for instrumental variable estimation; we consider
the ratio method, two-stage methods, likelihood-based methods, and semi-parametric methods.
Techniques for obtaining statistical inferences and confidence intervals are presented. The statistical
properties of estimates from these methods are compared, and practical advice is given about
choosing a suitable analysis method. In particular, bias and coverage properties of estimators are
considered, especially with weak instruments. Settings particularly relevant to Mendelian randomization
are prioritized in the paper, notably the scenario of a continuous exposure and a continuous or binary
outcome.
Keywords
Instrumental variable, comparison of methods, causal inference, weak instruments, finite-sample bias,
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1 Introduction
Instrumental variable analysis is the exploitation of a natural experiment to obtain causal inferences
in an observational setting. An instrumental variable is a factor that is correlated with the exposure
(usually a putative causal risk factor), but is not associated with any confounder of the exposure–
outcome association, nor is there any pathway by which the instrumental variable can inﬂuence the
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outcome other than via the exposure of interest.1,2 Usually, an instrumental variable is in some way
external to the relationship between the exposure and outcome and formally must be exogenous to
the statistical model relating the exposure to the outcome (that is, not associated with the error term
in the equation).3 A natural experiment is analogous to a randomized trial, except that the value of
the exposure is inﬂuenced by nature rather than by an investigator on the basis of randomized
allocation.4
A source of potential instrumental variables is genetic variants.5 A genetic variant is a section of
genetic code that diﬀers between individuals. Genetic variants are good candidate instrumental
variables: the function of many genes is known and well characterized; genetic variants are ﬁxed
at conception, and so do not change due to environmental factors, thus avoiding reverse causation;
and genetic variants are generally inherited independently, meaning that they tend to be speciﬁc in
their associations. The use of genetic variants as instrumental variables in observational data has
been termed ‘Mendelian randomization’.6,7
Many reviews exist on the use of instrumental variables, in particular on the assumptions
necessary to be an instrumental variable,8,9 assessing the validity of instrumental variables,10
assumptions necessary for estimation of a causal eﬀect parameter using instrumental
variables,11–13 methods for eﬀect estimation with multiple instrumental variables,14 with binary
outcomes,15,16 methods for the estimation of odds ratios,17 and guidelines for the reporting of
instrumental variable analysis.18 We seek to complement this literature by contributing a review
to compare methods for instrumental variable analysis, with accompanying practical guidelines on
their use. This review will focus on methodological issues that are particularly relevant to Mendelian
randomization: the scenario of a continuous exposure and a continuous or binary outcome;
statistical inference and the construction of conﬁdence intervals; and the use of multiple
instruments, in particular multiple weak instruments. A ‘weak instrument’ is an instrumental
variable that explains a relatively small proportion of variance in the exposure.19 Although these
are issues particularly germane to Mendelian randomization, they are also relevant to instrumental
variable analyses in other contexts.
After framing the typical context of a Mendelian randomization investigation that we assume to
hold (Section 2), we proceed to consider in turn the ratio of coeﬃcients method (Section 3), two-
stage methods (Section 4), likelihood-based methods (Section 5), and semi-parametric methods
(Section 6). This order corresponds roughly to the complexity of the methods, with the simplest
ones ﬁrst. This is not an exhaustive list of methods that have been proposed for instrumental
variable analysis, but it covers a wide range of commonly used methods. The methods are
contrasted in terms of bias, coverage, eﬃciency, robustness to misspeciﬁcation, and the existence
of ﬁnite moments. We outline the problem of weak instruments and present a comparison of
estimates from methods with weak instruments (Section 7). We also introduce a score-based (or
‘allele score’) approach to instrumental variable estimation, conceived for use with multiple weak
instruments. We conclude by discussing methodological issues relating to the eﬃciency and validity
of instrumental variable analyses, and to the use of instrumental variable methods in practice
(Section 8).
2 Context of the problem
We assume that individual-level data are available from a single data source on an exposure X, an
outcome Y, and an instrumental variable (IV) Z, or set of IVs Z1, Z2, . . ., ZK. Usually the outcome is
disease, although there is no methodological restriction as to what outcomes can be considered.
The exposure is a putative causal risk factor for the outcome and is assumed to be continuous.
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A binary exposure is common for IV estimation in the context of a randomized trial to estimate the
causal eﬀect of treatment, where the IV is randomization.20 In this case, randomization typically has
a large eﬀect on the treatment received for a subgroup of individuals known as the compliers.21
However, in Mendelian randomization, the exposure is almost always continuous, and genetic
variants typically have small eﬀects on the exposure that are thought to aﬀect all individuals in
the population. Although it is possible to consider a dichotomized risk factor as an exposure (such as
presence of hypertension in the case of blood pressure), a valid IV for the continuous exposure is not
generally a valid IV for the dichotomized exposure, as there is an alternative causal pathway from
the IV to the outcome via the true value of the continuous exposure.10
2.1 Genetic variants used in Mendelian randomization
We here provide a simplistic introduction to genetics with the aim of explaining the format of genetic
data used in applied Mendelian randomization investigations; more detailed information on genetics
for Mendelian randomization can be found in other papers.5,6,22
Genetic variants used as IVs in Mendelian randomization are usually single-nucleotide
polymorphisms (SNPs). A SNP is a variation at a single position of the DNA sequence in some
individuals in a population, where the DNA sequence has one letter replaced with another letter.
The diﬀerent possible letters that may appear at this position are known as alleles. Most SNPs are
diallelic, having two alleles: one that is more common, known as the wild-type or major allele, and
the other known as the variant or minor allele. For each individual, a SNP can be represented as a
random variable by the number of variant alleles; this can take the values 0, 1, or 2, because each
individual has two copies of the DNA sequence (two chromosomes). In some cases, the SNP may be
regarded as a dichotomous variable, taking values 0 and 1: either for statistical reasons, if the
variant allele is rare so that only a very small number of individuals in the sample have two
copies, or for biological reasons, if individuals with a single copy of the variant allele have similar
average values of the exposure as those with zero copies (recessive model) or as those with two copies
(dominant model). Alternatively, the IV may be a copy number variant (a repeated section of the
DNA code where the number of copies of the section varies between individuals),23 or an allele score
(Section 7.3); in these cases, the IV would be a discrete variable taking positive values or a
continuous variable.
2.2 Causal estimand
It has been established that the core IV assumptions only identify bounds for the causal eﬀect rather
than a single causal estimate.24,25 However, these bounds are extremely imprecise and even in large
samples are rarely informative. We do not recommend their use in practical Mendelian
randomization investigations. We here assume that the IV assumptions are satisﬁed; otherwise,
even these bounds can be biased and highly misleading, particularly if the IVs are weak.26
With a binary exposure and a single IV, under the assumption of monotonicity in the eﬀect of the
IV on the exposure, the causal estimand from an IV analysis is known as a local average treatment
eﬀect27 or (in particular in the case of a binary IV) a complier-averaged causal eﬀect.28 It represents
the average change in the outcome for a change in the exposure amongst those individuals
whose value of the exposure is aﬀected by their value of the IV.11 Monotonicity means that the
exposure for each individual would be increased (or alternatively for each individual would be
decreased) or unchanged if that person had Z ¼ z1 compared to if they had Z ¼ z0 for all
z14 z0. In the language of principal stratiﬁcation for randomized trials, this is equivalent to the
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assumption that there are no deﬁers.21 For genetic variants that have proven biological links with
the risk factor, the monotonicity assumption is plausible, as such biological eﬀects seem likely to act
in the same direction across all individuals. However, the monotonicity assumption is unlikely to
hold if the IV is an allele score (Section 7.3), particularly if it is an unweighted or imprecisely
weighted score. In any case, the monotonicity assumption is not testable from empirical data.
If the monotonicity assumption is not satisﬁed, then the causal eﬀect of the exposure on the
outcome can be estimated consistently if it is constant for all individuals across the population.29
A weaker version of this assumption, that of no modiﬁcation of the causal eﬀect across levels of the
instrument within the treated, can be used to estimate the eﬀect of treatment in the treated.30
With a continuous exposure, to identify a causal parameter, it is necessary to make
some parametric assumptions, for example homogeneity and linearity in the causal exposure–
outcome association with no eﬀect modiﬁcation.9,12 The causal estimand is then the average
change in the outcome for a unit change in the exposure. If there are multiple IVs, it is
convenient to assume that the causal eﬀect of the exposure on the outcome is homogeneous, so
that all the IVs identify the same causal quantity. However, this assumption is questionable,
particularly if the genetic variants used as IVs aﬀect diﬀerent biological pathways and so aﬀect
the value of the exposure in diﬀerent ways. This assumption is best addressed by a sensitivity
analysis, comparing IV estimates based on diﬀerent subsets of IVs, particularly if the subsets
correspond to groups of genetic variants with distinct biological functions, and can be tested
formally by an overidentiﬁcation test (Section 8.3).
With a binary outcome, it is common in conventional observational studies to express the
association of interest as a relative risk or an odds ratio, rather than as an average change in the
outcome (which would represent an eﬀect on the risk diﬀerence scale). This is problematic in the case
of an odds ratio, as the odds ratio is a non-collapsibility measure of association, meaning that its
value depends on the distribution of risk factors in the population that aﬀect the outcome even if
these variables are not confounders of the relationship between the exposure and outcome.31 It is
therefore recommended that odds ratios should only be estimated in a case–control setting, as other
measures of association are sensitive to case–control sampling. We return to the problem of deﬁning
and estimating a causal odds ratio in the context of the individual IV methods.
In this paper, we presume that a causal eﬀect estimate is the desired outcome of a Mendelian
randomization analysis. In many cases, testing for an association between an IV and the outcome, to
assess the causal role of the exposure and the direction of the causal eﬀect without estimating a
causal parameter, is suﬃcient.32 Such a test can be performed by a variety of methods, but most
commonly using linear regression with a continuous outcome and using linear or logistic regression
with a binary outcome. Although a causal estimate is likely to diﬀer from the eﬀect of a clinical
intervention on the same exposure in practice,7 an eﬀect estimate may be desired, for instance, to
give a quantitative indication of the importance of the exposure in relation to the outcome. We
proceed to consider various methods for IV estimation in the context described above; however,
deviations in many of these features (such as the availability of individual-level data, linearity of the
causal eﬀect, homogeneity of the IV estimate from diﬀerent IVs) are addressed throughout the paper
and in particular in the discussion.
3 Ratio of coefficients method
The ratio of coeﬃcients method, or the Wald method,33 is the simplest way of estimating the causal
eﬀect of the exposure (X) on the outcome (Y). The ratio method uses a single IV (Z); all other
methods in this paper are able to include data on multiple IVs.
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3.1 Continuous outcome
If the coeﬃcient of the IV in the regression of the exposure on the IV is written as ^XjZ and the
coeﬃcient of the IV in the regression of the outcome on the IV is written as ^YjZ, then the ratio
estimate of the causal eﬀect is
Ratiomethod estimate ¼ ^YjZ
^XjZ
ð1Þ
Intuitively, we can think of the ratio method as saying that the change in the outcome for a unit
increase in the exposure is equal to the change in the exposure for a unit increase in the IV, scaled by
the change in the exposure for a unit increase in the IV. The causal estimate is usually expressed as
the change in the outcome resulting from a unit change in the exposure, although changes in the
outcome corresponding to diﬀerent magnitudes of change in the exposure could be quoted instead.
If the IV is dichotomous, taking values 0 and 1, then the ratio estimate simpliﬁes to
Ratiomethod estimate ðdichotomous IVÞ ¼ y1  y0
x1  x0 ð2Þ
where y1 is the average value of the outcome amongst those with an IV value of 1, and so on. If the
eﬀect of the exposure on the outcome is assumed to be linear, then the ratio estimate is the causal
eﬀect on the outcome of an exposure of xþ1 units versus an exposure of x units. If the eﬀect is not
linear, then theoretical and empirical considerations have demonstrated that the ratio estimate
approximates an average causal eﬀect of a population intervention in the exposure, for the
population under analysis, with the assumption that the eﬀect of the IV on the exposure is
constant in the population34 (Section 8.1).
We note that the ratio estimate can be calculated simply from the coeﬃcients ^XjZ and ^YjZ and as
such only requires the availability of summarized data, not individual-level data, from the population.
We return to consider IV estimation using summarized data in more detail in Section 8.6.
3.2 Binary outcome
Generally in epidemiological applications, disease is the outcome of interest. Disease outcomes are
often dichotomous. We use the epidemiological terminology of referring to an individual with an
outcome event as a case (Y¼1), and an individual with no event as a control (Y¼0).
With a binary outcome, the coeﬃcient ^YjZ in the ratio estimate (equation (1)) is again taken
from regression of the outcome on the IV. The regression model used could in principle be linear, so
that the IV estimate represents the change in the probability of an event for a unit change in the
exposure. However, with a dichotomous outcome, log-linear or logistic regression models
are generally preferred by epidemiologists, where the IV estimate represents the log relative risk
or log odds ratio, respectively, for a unit change in the exposure. In a case–control setting, measures
based on risk diﬀerences depend on the choice of the ratio of cases to controls, whereas odds ratios
are invariant to outcome-dependent sampling. More generally, relative risks and odds ratios (which
approximate relative risks under the rare disease assumption35) are based on multiplicative risk
models, which may be more plausible than additive risk models, and are easier to communicate.36
With a dichotomous IV, the ratio estimate simpliﬁes as with a continuous outcome
Ratiomethod log relative risk or log odds ratioð Þ estimate ðdichotomous IVÞ ¼ y1  y0
x1  x0 ð3Þ
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where yj is the log of the probability of an event, or the log odds of an event, in IV subgroup j¼0,1.
If the structural model relating the log of the probability of the outcome to the exposure is linear
in the exposure with no eﬀect modiﬁcation, then the ratio estimate calculated using log-linear
regression will be consistent for the causal log relative risk.12 The analogous consistency property
does not hold in the case of a logistic-linear relationship between the probability of the outcome and
the exposure, as the odds ratio is not a collapsible measure of association (see Section 4.2).
3.3 Case–control data
When case–control data are available, it is usual to make inferences on the IV-exposure association
using only the controls.37 This makes the assumption that the association of the IV with the
exposure in the controls is similar to that in the general population, which is true for a rare
disease.38 This is necessary for two reasons. The ﬁrst is reverse causation, as measurements of the
exposure in a retrospective setting may be distorted by a disease event. Second, over-recruitment of
cases into the study means that the distribution of confounders in the case–control sample is
diﬀerent to that in the general population. An association may be induced between the IV and
the confounders, leading to possible bias in the IV estimate.9 This aﬀects not only the ratio method
but all IV methods. The IV–outcome association estimate should not be aﬀected provided that
logistic regression is used, as logistic regression estimates are invariant to outcome-dependent
sampling. It is also necessary to assume that the probability of recruitment into the study is not
dependent on the genetic variants used as IVs. For example, a genetic variant associated with
increased mortality after an outcome event would appear to be protective rather than deleterious
if the individuals who died were excluded from the study.
If the outcome is common and its prevalence in the population from which the case–control
sample was taken is known, such as in a nested case–control study, then inferences on the
IV–exposure association can be obtained using both cases and controls, provided that
measurements of the exposure in cases were taken prior to the outcome event. This analysis
can be performed by weighting the sample so that the proportions of cases and controls in the
reweighted sample match those in the underlying population.38
3.4 Confidence intervals
Conﬁdence intervals for the ratio estimate can be calculated in several ways.
3.4.1 Normal approximation
The simplest way is to use a normal approximation. With a continuous outcome, standard errors
and conﬁdence intervals can be taken from the two-stage least squares method (see Section 4).
Alternatively, the following approximation can be used, based on the ﬁrst terms of the delta
method expansion for the variance of a ratio
Asymptotic standard
error of ratio estimate
¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
seð^YjZÞ
2
^XjZ
2
þ ^YjZ
2
seð^XjZÞ
2
^XjZ
4
 2 ^YjZ covð^XjZ, ^YjZÞ
^XjZ
3
vuuut ð4Þ
If the numerator and denominator of the ratio estimator are uncorrelated, then the third term can
be omitted; in any event, such correlation is unlikely to have a considerable impact on conﬁdence
intervals.39
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However, asymptotic normal approximations for the IV estimate may result in overly narrow
conﬁdence intervals, especially if the sample size is not large or the IV is weak (Section 7). This is
because IV estimates are not normally distributed.19
3.4.2 Fieller’s theorem
Alternatively, if the regression coeﬃcients in the ratio method ^YjZ and ^XjZ are assumed to be
normally distributed, critical values and conﬁdence intervals for the ratio estimator may be
calculated using Fieller’s theorem.5,40 Fieller’s theorem gives conﬁdence intervals that have one of
three possible forms41:
(i) The interval may be a closed interval [a,b],
(ii) The interval may be the complement of a closed interval (1,b][[a,1), and
(iii) The interval may be unbounded.
where a and b are functions of the association estimates ^YjZ and ^XjZ and their standard errors.
Conﬁdence intervals from Fieller’s theorem may be preferred to those from an asymptotic normal
approximation when the IV is weak.42 A tool to calculate conﬁdence intervals from Fieller’s theorem
is available online (https://sb452.shinyapps.io/ﬁeller).
3.4.3 Bootstrapping
As an alternative approach, also applicable to any of the following methods, conﬁdence intervals
can be calculated by bootstrapping.43 The simplest way of constructing a bootstrapped conﬁdence
interval is by taking several random samples with replacement from the data of the same sample size.
The empirical distribution of the IV estimator in the bootstrapped samples approximates the true
distribution of the IV estimator.44 However, there are some concerns about the behaviour of
bootstrapped conﬁdence intervals with weak instruments.45
3.4.4 Other approaches
Alternative approaches for inference with weak instruments not discussed further here are
conﬁdence intervals based on inverting a test statistic, such as the Anderson–Rubin test
statistic46 or the conditional likelihood ratio test statistic.47 A variance estimator for a
generalized empirical likelihood approach with good coverage properties has also been
developed.48 These intervals give appropriate conﬁdence levels under the null hypothesis with
weak instruments but may be underpowered with stronger instruments. However, unlike Fieller’s
theorem, Anderson–Rubin and conditional likelihood ratio test conﬁdence intervals can be
calculated based on multiple IVs. These methods have been discussed in detail elsewhere49,50 and
implemented in Stata51 and R.52 We recommend the Fieller’s theorem, Anderson–Rubin, or
conditional likelihood ratio approaches for obtaining causal inferences and conﬁdence intervals
in practice with a weak instrument.
3.5 Absence of finite moments
One peculiar property of the ratio estimator is that its mean is not ﬁnite.53,54 This implies that, if
you generated data on the exposure and outcome from a model with a valid IV and calculated
the ratio estimate a large number of times, the mean value of these ratio estimates would
become arbitrarily high (or low). This is due to the fact that there is a ﬁnite probability that
the denominator in the ratio estimate (^XjZ) is very close to zero, leading to a large IV estimate.
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In practice, this is unlikely to be a serious issue since, if ^XjZ were close to zero, the IV would be
considered invalid as the assumption that the IV is associated with the exposure would appear to
be violated. Theoretically, the absence of a ﬁnite mean makes comparison of IV methods more
diﬃcult, as the (mean) bias of the ratio estimate, deﬁned as the diﬀerence between the mean of
the IV estimator over its distribution and the true value of the causal eﬀect, cannot be
calculated. We therefore additionally consider the median bias, the diﬀerence between the
median of the IV estimator and the true causal eﬀect, when comparing diﬀerent methods for
IV estimation.19
4 Two-stage methods
A two-stage method comprises two regression stages: the ﬁrst-stage regression of the exposure on the
IVs, and the second-stage regression of the outcome on the ﬁtted values of the exposure from
the ﬁrst stage. Both two-stage and likelihood-based methods (Section 5) make parametric
assumptions for the identiﬁcation of causal eﬀects; this is contrasted with the weaker semi-
parametric associations of the methods introduced in Section 6.
4.1 Continuous outcome – Two-stage least squares
With continuous outcomes and a linear model, the two-stage method is known as two-stage least
squares (2SLS). It can be used with multiple IVs. In the ﬁrst-stage regression, the exposure (X) is
regressed on the IV(s) (Z) to give ﬁtted values of the exposure (X^jZ). In the second-stage regression,
the outcome (Y) is regressed on the ﬁtted values for the exposure (X^jZ) from the ﬁrst-stage
regression. The causal estimate is this second-stage regression coeﬃcient for the change in the
outcome caused by a unit change in the exposure.
With a single IV, the 2SLS estimate is the same as the ratio estimate. With multiple IVs, the 2SLS
estimator may be viewed as a weighted average of the ratio estimates calculated using the
instruments one at the time, where the weights are determined by the relative strengths of the
instruments in the ﬁrst-stage regression.55
Suppose we have K instrumental variables available. With data on individuals indexed by
i¼ 1, . . . ,N who have exposure xi, outcome yi and assuming an additive linear model for the IVs
zik indexed by k¼ 1, . . . ,K, the ﬁrst-stage regression model is
xi ¼ 0 þ
X
k
kzik þ "Xi ð5Þ
The ﬁtted values x^i ¼ ^0 þ
P
k ^kzik are then used in the second-stage regression model
yi ¼ 0 þ 1x^i þ "Yi ð6Þ
where "Xi and "Yi are independent error terms. The causal parameter of interest is 1. If both models
are estimated by standard least-squares regression, both the error terms are implicitly assumed to be
homoscedastic and normally distributed.
Although estimation of the causal eﬀect in two stages (a sequential regression method) gives the
correct point estimate, the standard error from the second-stage regression (equation (6)) is not
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correct.56(p. 188) This is because it does not take into account the uncertainty in the ﬁrst-stage
regression. Under homoscedasticity of the error term in the equation
yi ¼ 0 þ 1xi þ "0Yi ð7Þ
the asymptotic variance of the 2SLS estimator is
^2ðXTZðZTZÞ1ZTXÞ1 ¼ ^2ðX^TX^Þ1 ð8Þ
where ^2 is an estimate of the variance of the residuals from equation (7), and Z is a N by Kþ 1
matrix of the IVs (including a constant term) and X is a N by 2 matrix of the risk factor and a
constant term. Robust standard errors are often used in practice, as estimates are sensitive to
heteroscedasticity and misspeciﬁcation of the equations in the second-stage model. However, in
the continuous outcome case, consistent estimates are obtained even when the ﬁrst-stage model is
misspeciﬁed.57
When all the associations are linear and the error terms normally distributed, the 2SLS estimator
has a ﬁnite kth moment when there are at least (kþ1) IVs.53 Therefore, the mean of a 2SLS estimator
is only deﬁned when there are at least 2 IVs, and the variance is only deﬁned when there are at least
3 IVs. Unlike in an observational analysis, in which estimates from conventional regression
(ordinary least squares) are attenuated by measurement error in the exposure,58 the bias of eﬀect
estimates from the 2SLS method (and consequently from the ratio method amongst others) is not
aﬀected by classical (non-diﬀerential) measurement error in the exposure.59
4.2 Binary outcome
The analogue of 2SLS with binary outcomes is a two-stage estimator where the second-stage
(exposure–outcome) regression uses a log-linear or logistic regression model. These methods are
implemented in order to estimate a causal relative risk or odds ratio parameter. They can be
implemented using a sequential regression method by performing the two regression stages in
turn. Estimates from such an approach will be overly precise, as uncertainty in the ﬁrst-stage
regression is not accounted for; however, this over-precision may be slight if the standard error in
the ﬁrst-stage coeﬃcients is low. This can be resolved by the use of a likelihood-based method
(Section 5.3) or a bootstrap method.60
As with the ratio IV estimator, in a case–control study, it is important to undertake the ﬁrst-stage
regression only in the controls, not the cases (Section 3.3). Fitted exposure values for the cases are
obtained by substituting their IV values into the ﬁrst-stage regression model.
Two-stage regression methods with non-linear second-stage regression models (such as logistic
regression) have been criticized and called ‘forbidden regressions’.56(p. 190) This is because the non-
linear model does not guarantee that the residuals from the second-stage regression are uncorrelated
with the instruments.61 There is current debate about the interpretation and validity of such
estimates, especially when the measure of association is non-collapsible.
A measure of association, such as an odds ratio or relative risk, is collapsible if, when it is
constant across the strata of the covariate, this constant value equals the value obtained from the
overall (marginal) analysis. Non-collapsibility is the violation of this property.62 The relative risk
and absolute risk diﬀerence are collapsible measures of association. Odds ratios are generally non-
collapsible.63 An odds ratio estimated in an observational study by conventional multivariable
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logistic regression is conditional on those covariates adjusted for in the analysis. Unless adjustment
is made (Section 8.2), an odds ratio estimated in an IV analysis is marginal on these covariates. The
odds ratio from a ratio or two-stage analysis method is conditional on the IV, but marginal in all
other variables, including the exposure itself if it is continuous.64 This approximates a population-
averaged odds ratio from a randomized trial, where the intervention is to increase the exposure by
one unit in all individuals across the population.42 A population-averaged odds ratio can be
calculated as the average odds in the population for one value of the exposure distribution
divided by the average odds for another value of the exposure distribution – for instance, the
distribution of the exposure in the population increased uniformly by one unit, and the original
distribution of the exposure in the population.
Despite the consequences of non-collapsibility, the two-stage estimator with a logistic second-
stage model still provides a valid test of the null hypothesis.17
4.3 Adjusted two-stage method
An adjusted two-stage method has been proposed, where the residuals from the ﬁrst-stage regression
are included in the second-stage regression. This has been referred to as a control function
approach,65 or two-stage residual inclusion method.66 If we have a ﬁrst-stage regression of X on
Z with ﬁtted values X^jZ and residuals R^jZ ¼ X X^jZ, then the adjusted two-stage estimate comes
from a second-stage regression additively on X^jZ and R^jZ (or equivalently on X and R^jZ). The
residuals from the ﬁrst-stage regression incorporate information on confounders.
If the outcome is continuous, then inclusion of these residuals in a second-stage linear regression
model does not change the estimate, as the residuals are orthogonal to the ﬁtted values. If the
outcome is binary, inclusion of these residuals in a second-stage logistic regression model implies
that the IV estimate is conditional on these residuals. Numerically, it brings the IV estimate closer to
the subject-speciﬁc log odds ratio; the parameter 1 in a logistic-linear model
67
logit P Y ¼ 1jX ¼ x,U ¼ uð Þ ¼ 0 þ 1xþ 2u ð9Þ
where U represents all other covariates (whether confounders or not) in the probability model. Some
investigators have therefore recommended the adjusted two-stage method when the second-stage
regression is logistic on the premise that it is less biased than the unadjusted two-stage method.66
Under a particular choice of mathematical model in which the ﬁrst-stage residual is equal (up to a
multiplicative constant) to the term 2u in equation (9), the adjusted two-stage estimate is consistent
for the parameter 1.
66 However, this mathematical model is unrealistic, and in general the adjusted
two-stage estimate is biased for this parameter.15,68 Further, when the covariates are unknown, as is
usual in an IV analysis, it is not clear what variable is represented by the ﬁrst-stage residuals, and so
which covariates the adjusted two-stage estimate is conditional on and which it is marginal across.
It is uncertain what odds ratio is being estimated by an adjusted two-stage approach, that is, to what
question is the adjusted two-stage estimate the answer. We therefore do not recommend adjustment
for the ﬁrst-stage residuals in a two-stage method.
5 Likelihood-based methods
The above methods are not likelihood based and do not provide maximum likelihood estimates,
which have the desirable properties of asymptotic unbiasedness, normality, and eﬃciency. So we
next consider likelihood-based methods.
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5.1 Limited information maximum likelihood
If each individual i¼ 1, . . . , N has exposure xi, outcome yi, and IVs zik indexed by k¼ 1, . . . ,K, we
can assume the following model
xi ¼ 0 þ
X
k
kzik þ "Xi ð10Þ
yi ¼ 0 þ 1xi þ "Yi
where the two error terms have a bivariate normal distribution.46 (These error terms diﬀer from
those deﬁned in equations (5) and (6).) The causal parameter of interest is 1. Correlation between
"X and "Y is due to confounding. We can calculate the maximum likelihood estimates of 1 and each
of the other parameters in the model. This is known as limited information maximum likelihood
(LIML; see Section 18.5 in Davidson and MacKinnon69). Conﬁdence intervals can be obtained by
the assumption of asymptotic normality of the parameter estimates.
The term ‘limited information’ means that only limited information on the structure of the model is
used. In particular, if there were multiple outcomes or risk factors, only parameters from a single
equation are estimated. This is in contrast to full information maximum likelihood or three-stage least
squares (3SLS),70 in which the whole system of equations in the model is estimated simultaneously.
Full-system methods have the potential advantage of eﬃciency, but the disadvantage of inconsistent
estimation if one or more of these equations are misspeciﬁed. However, in the context of Mendelian
randomization with a single outcome and a single risk factor, there is no distinction.
LIML has been called the ‘maximum likelihood counterpart of 2SLS’71(p. 227) and gives the same
causal estimate as the 2SLS and ratio methods with a single IV. As with 2SLS, estimates are sensitive
to heteroscedasticity and misspeciﬁcation of the equations in the model. Use of LIML has been
strongly discouraged by some, as LIML estimates do not have deﬁned moments for any number of
instruments.54 However, use has also been encouraged by others, especially with weak instruments,
as the median of the distribution of the LIML estimator is close to unbiased even with weak
instruments.56(p. 209)
The LIML estimate can be intuitively understood as the eﬀect 1 that minimizes the residual sum
of squares from the regression of the component of the outcome not caused by the exposure,
ðyi  1xiÞ, on the IV(s). Informally, the LIML estimator is the causal parameter for which the
component of the outcome due to confounding is as badly predicted by the IVs as possible.
5.2 Bayesian methods
Inferences from a likelihood model can also be obtained in a Bayesian framework.72 Here, we
consider a slightly diﬀerent likelihood model from equation (10) that has been discussed
previously in the literature.42 For each individual i, we model the observed exposure and outcome
as coming from a bivariate normal distribution for Xi,Yið ÞT with mean ði, iÞT and variance-
covariance matrix
P
. The mean of the exposure distribution i is assumed to be a linear function
of the instruments zik, k ¼ 1, . . . ,K, and the mean of the outcome distribution i is assumed to be a
linear function of the mean exposure i
73
Xi
Yi
 
 N2
i
i
 
,
 
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i ¼ 0 þ
X
k
kzik
i ¼ 0 þ 1i ð11Þ
This model is similar to that for the LIML method, except that the causal parameter 1 represents
the causal eﬀect between the true means i and i rather than the measured values of outcome and
exposure. The model can be estimated in a Markov chain Monte Carlo framework, such as that
implemented in WinBUGS.74 The output is a posterior distribution, from which the posterior mean
or median can be interpreted as a point estimate, and the 2.5th and 97.5th percentiles as a ‘95%
conﬁdence interval’. With vague priors, the posterior distribution is similar to the frequentist
likelihood function.42
An advantage of the Bayesian approach is that, under the modelling assumptions, valid
inferences can be obtained that are not based on asymptotic results, but rather on the posterior
distribution of the causal parameter. Simulations have shown that frequentist properties of inference
(such as coverage levels) are more robust in the Bayesian approach with weak instruments.42
5.3 Likelihood-based methods with binary outcomes
Maximum likelihood and Bayesian methods can be applied to binary outcomes. If we assume a
linear model of association between the logit-transformed probability of an event (i) and the
exposure (a logistic-linear model), and a Bernoulli distribution for the outcome event, as in the
following model
xi  Nði, 2XÞ
yi  BernoulliðiÞ
i ¼ 0 þ
XK
k¼1
kzik
logitðiÞ ¼ 0 þ 1i þ 2ðxi  iÞ
ð12Þ
Estimates can be obtained by maximization of the joint likelihood, or in a Bayesian framework,
obtaining posterior distributions by Markov chain Monte Carlo methods. Inclusion of the
coeﬃcient 2 is similar to a control function approach (Section 4.3), in which the ﬁrst-stage
residual is adjusted for in the second-stage regression of a two-stage method. Alternatively, this
term can be omitted, although formally this results in the likelihood model being misspeciﬁed.42
Simulations have suggested that both approaches give reasonable estimates, although they are
aﬀected by non-collapsibility.
Log-linear models can in principle be estimated in the same way, although care is needed to
ensure that the probabilities i do not exceed 1 at any point in the estimation procedure.
5.4 Comparison of two-stage and likelihood-based methods
In the two-stage methods, the two stages are performed sequentially. The output from the ﬁrst-stage
regression is fed into the second-stage regression with no acknowledgement of uncertainty. In the
likelihood-based methods, the two stages are performed simultaneously: the  and  parameters
are estimated at the same time. Uncertainty in the ﬁrst-stage parameters is acknowledged and
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feedback between the regression stages is possible. The uncertainty in the estimate of the causal
parameter 1 is therefore better represented in the likelihood-based approaches if there is
non-negligible uncertainty in the ﬁrst-stage regression model. This provides a heuristic
justiﬁcation why likelihood-based methods perform better than two-stage methods with weak
instruments (see Section 7).
5.5 k-class estimators
The LIML and 2SLS estimators are part of a wider class of estimators known as k-class
estimators.75 The k-class estimator of the causal eﬀect 1 from equation (10) is
^k ¼ ½YTðI kPZÞY1½YTðI kPZÞX ð13Þ
where Y is a N by 1 matrix of the outcome, Z is a N by Kþ1 matrix of the IVs (including a constant
term), and X is a N by 2 matrix of the risk factor and a constant term. The matrix
PZ ¼ I Z ZTZ
 1
ZT is the projection matrix of Z.76 If k¼1, then ^k is the 2SLS estimator. If k
is the smallest root of det YTY kYTPzY
  ¼ 0, then ^k is the LIML estimator. Several other choices
are available, including the bias-corrected 2SLS estimator,54 and Fuller’s k estimator.77 These
estimators are beyond the scope of this review.
6 Semi-parametric methods
A semi-parametric model has both parametric and non-parametric components. Typically semi-
parametric estimators with IVs assume a parametric form for the model relating the outcome and
exposure, but make no assumption on the distribution of the errors. Semi-parametric models are
designed to be more robust to model misspeciﬁcation than fully parametric models.78
6.1 Generalized method of moments
The generalized method of moments (GMM) is a semi-parametric estimator designed as a more
ﬂexible form of 2SLS to deal with problems of heteroscedasticity of error distributions and non-
linearity in the two-stage structural equations.61,79 With a single instrument, the estimator is chosen
to give orthogonality between the instrument and the residuals from the second-stage regression.
Using bold face to represent vectors, if we have
EðYjdoðX ¼ xÞÞ ¼ f ðx;bÞ ð14Þ
then the GMM estimate is the value of b such that
X
i
yi  f yi; bð Þð Þ ¼ 0
and
X
i
zi yi  f yi; bð Þð Þ ¼ 0
ð15Þ
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where the summation is across i, which indexes study participants. Equation (14) is a structural
model, where EðYjdoðX ¼ xÞÞ is the expectation of the distribution that Y would take if we forced X
to equal x for all individuals.80
In the linear (or additive) case, f yi; bð Þ ¼ 0 þ 1xi; in the log-linear (or multiplicative) case,
f yi; bð Þ ¼ expitð0 þ 1xiÞ; and in the logistic case, f yi; bð Þ ¼ expitð0 þ 1xiÞ; where 1 is our
causal parameter of interest and expitðzÞ ¼ ð1 expðzÞÞ1, the inverse of logit(z). We can solve
the two equations in (15) numerically.16
GMM estimates are sensitive to the parameterization used. For example, estimates from the
estimating equations (15) and from X
i
yi f yi; bð Þ1  1
  ¼ 0
andX
i
zi yi f yi;bð Þ1  1
  ¼ 0
ð16Þ
may be diﬀerent in ﬁnite samples, although they each assume the same structural model between the
outcome and exposure. With a binary outcome, the second set of estimating equations is usually
used, as this corresponds to a multiplicative error structure.15
When there is more than one IV, zi becomes zik and we have a separate estimating equation for
each instrument k¼1, . . . ,K. The orthogonality conditions for each instrument cannot generally be
simultaneously satisﬁed. The estimate is usually taken as the minimizer of the objective function
ðy f ðx; bÞÞTZðZTZÞ1ZTðy f ðx;bÞÞ ð17Þ
where Z ¼ ð1z1 . . . zKÞ is the N by Kþ 1 matrix of instruments, including a column of 1s. Although
this gives consistent estimation for general matrix , eﬃcient estimation is achieved when
ij ¼ covð"i, "jÞ (i,j¼ 1, . . . ,N), where ei is the residual yi  f ðyi;bÞ.81
As the estimation of  requires knowledge of the unknown b, a two-step approach is suggested.
We ﬁrstly estimate b* using ðZTZÞ ¼ I, where I is the identity matrix, which gives consistent but
not eﬃcient estimation of b. We then use ei ¼ yi  f ðyi;bÞ to estimate ZTZ ¼
P
i
zizi
T"2i asP
i
zizi
Te2i in a second-stage estimation.
79
6.2 Continuous updating estimator
An alternative approach is to express the weighting matrix  as a function of the causal parameter,
and then to estimate the causal parameter and weighting matrix simultaneously by minimizing
equation (17). This is known as the continuous updating estimator (CUE), as the weighting matrix
updates during the estimation procedure.82 The CUE is similar to the LIML estimator in terms of
conﬁdence intervals and ﬁnite sample bias,48 and the two estimators are equivalent if the residuals ei
deﬁned above are homoscedastic.83 However, the CUE does not make the homoscedasticity
assumption. The CUE and two-step GMM estimators have the same asymptotic distribution.83
6.3 G-estimation of structural mean models
G-estimation of a structural mean model (SMM) is another semi-parametric estimation method84,85
designed in the context of randomized trials with incomplete compliance.86,87 The potential outcome
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Y(x) is deﬁned as the outcome which would have been observed if the exposure X were set to x. In
particular, the exposure-free outcome Y(0) is the outcome which would have been observed if we
had set X to 0 rather than it taking its observed value of x.78
An explicit parametric form is assumed for the expected diﬀerence in potential outcomes between
the outcome for the observed X¼ x and the potential outcome for X¼0. In the continuous case, the
linear or additive SMM is
EðYðxÞ  Yð0ÞjX ¼ x,Z ¼ zÞ ¼ 1x ð18Þ
and b1 is taken as the causal parameter of interest. In the context of non-compliance, this is referred
to as the ‘eﬀect of treatment on the treated’.88 In this equation, there is no eﬀect modiﬁcation on the
additive scale by Z.
As the expected exposure-free outcome E(Y(0)WX¼ x,Z¼ z) is statistically independent of Z, the
causal eﬀect is estimated as the value of b1 which gives zero covariance between
EðYð0ÞjX ¼ x,Z ¼ zÞ ¼ EðYðxÞ  1xjX ¼ x,Z ¼ zÞ and Z. The estimating equations areX
i
ðzik  zkÞðyi  1xiÞ ¼ 0 k ¼ 1, . . . ,K ð19Þ
where zk ¼ 1N
P
i
zik and the summation is across i, which indexes study participants.
Where the model for the expected outcomes is non-linear, this is known as a generalized SMM.
With a binary outcome, it is natural to use a log-linear (or multiplicative) SMM
logEðYðxÞjX ¼ x,Z ¼ zÞ  logEðYð0ÞjX ¼ x,Z ¼ zÞ ¼ 1x ð20Þ
In this case, there is no eﬀect modiﬁcation by Z on the multiplicative scale.
The linear (additive) and log-linear (multiplicative) GMM and SMM approaches outlined give
rise to the same estimating equations, and so software for GMM estimation can also be used for the
estimation of a SMM.89 In the case of a single IV, the linear GMM and SMM estimates coincide
with the corresponding ratio estimate. With multiple IVs, the estimating equations are not
guaranteed to have a unique solution, and so an objective function can be obtained and
minimized in the same way as in the GMM approach. Eﬃcient estimates can be obtained using
the same two-step method outlined for the GMM approach in Section 6.1.90
Unfortunately, a logistic SMM cannot be deﬁned in the same way, as the moment conditions in
the estimating equations depend on unmeasured covariates due to the non-collapsibility of the odds
ratio.91 This problem also arises in the GMM case,15 although GMM is an estimation method and
so does not require the functional form relating the exposure and outcome to be given the
interpretation of a structural model. For a SMM, the problem can be resolved by estimating Y
assuming an observational model90
logitEðYjX ¼ x,Z ¼ zÞ ¼ 0a þ 1ax ð21Þ
where the subscripts a indicate associational, and substituting estimates of Y into the structural
model
logitEðYðxÞjX ¼ x,Z ¼ zÞ  logitEðYð0ÞjX ¼ x,Z ¼ zÞ ¼ 1cx ð22Þ
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where the subscript c indicates causal. The associational parameters can be estimated by logistic
regression, leading to estimating equationsX
i
ðzik  zkÞ expitðY^ðxÞ  1cxiÞ ¼ 0 k ¼ 1, . . . ,K ð23Þ
where Y^ðxÞ ¼ ^0a þ ^1ax.
6.4 Potential lack of unique estimate with binary outcomes
An issue with semi-parametric IV estimation in practice is that an estimate of the causal parameter
may not be uniquely determined in ﬁnite samples. A parameter in a statistical model is identiﬁed if
its value can be uniquely determined from the joint distribution of the observed variables in an
inﬁnite sample.92 However, for a semi-parametric instrumental variable analysis with a single IV and
a binary outcome, the estimating equations may be almost ﬂat in the vicinity of the solution to the
equations (known as weak identiﬁcation) or there may be multiple or no parameter values which
satisfy the estimating equations.93 This is especially likely if the IV is weak. Consequently, estimates
and standard errors reported by automated commands for GMM or SMM estimation can be
misleading.
It is recommended that applied investigators wanting to use a GMM or SMM approach should
plot the objective function of the relevant estimating equations for a large range of values of the
parameter of interest to check if there is a unique solution. If there is not, this should be reported as
an indication that there is a lack of information on the parameter in the data. An alternative
estimation technique can be used, such as a two-stage method, but identiﬁcation will then rely on
stronger assumptions.
A summary of features of the IV methods considered in this paper is given in Table 1. Having
discussed various methods for IV estimation, we proceed to consider practical issues in the
estimation of causal eﬀects, in particular the use of weak instruments.
7 Weak instruments
A ‘weak instrument’ is deﬁned as an IV for which the statistical evidence of association with the
exposure is not strong. A weak IV diﬀers from an invalid IV (one that does not satisfy the IV
assumptions) in that the IV estimate using a weak IV is asymptotically unbiased; a weak IV can be
made stronger by increasing the sample size. The F statistic in the regression of the exposure on the
Table 1. Summary table of features of instrumental variable methods considered in this paper.
Ratio method Can only be used with a single IV. Can be used with summarized data.
Two-stage methods Efficient, but biased with weak instruments. Robust to misspecification in the
first-stage model. Flexible to incorporate different exposure–outcome
models.
Likelihood-based methods Asymptotically efficient and less biased provided that the parametric assumptions
hold. Requires coding by hand outside of the linear case.
Semi-parametric methods Less efficient, less stringent assumptions. No guarantee of unique estimate in
finite samples.
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IV (also known as the Cragg–Donald F statistic94) is usually quoted as a measure of the strength of
an instrument.95 IV estimates demonstrate systematic ﬁnite sample bias, typically in the direction of
the observational (confounded) association between the exposure and outcome.96 IVs with an F
statistic less than 10 are often labelled as ‘weak instruments’.97 The value was chosen as the bias of
the 2SLS IV estimate with an IV having an expected F statistic value of 10 is limited to 10% of the
bias of the observational association. Such a binary characterization of IVs as weak or strong is
misleading, as the bias is a continuous phenomenon. Additionally, the expected magnitude of bias
does not depend on the value of the F statistic for a particular dataset, but the expected value of the
F statistic (also known as the concentration parameter95). The F statistic is highly variable between
datasets generated under the same data-generating mechanism, and so the F statistic in a given
dataset cannot be relied on as an accurate predictor of the expected bias in that dataset.19
7.1 Problems of estimates using weak instruments
Aside from the bias suﬀered by IV estimates with weak instruments, the distribution of such IV
estimates diﬀers substantially from a normal distribution. Conﬁdence intervals that rely on the
asymptotic normality of IV estimates (such as those typically reported by statistical software
packages for 2SLS or LIML methods) tend to underestimate the true uncertainty in the
estimates, leading to inﬂated Type I error rates. With large numbers of IVs (10 or more),
standard conﬁdence intervals from the LIML method with weak instruments are too narrow and
a correction is needed (known as Bekker standard errors).98,83 Tables have been produced for the
2SLS method giving the expected value of the F statistic at which the maximum possible Type I
error rate is less than 10%, 15%, 20%, and 25%.99 (Although the maximum error rate is only
achieved when the correlation between the exposure and outcome is one, so such extremes should
not be expected in practice.) The power of a study with weak instruments may also be low, although
this is not necessarily the case if there are many weak instruments. Correlation between IV estimates
and standard errors can lead to bias being accentuated in a meta-analysis of IV estimates, as in the
sampling distributions, estimates closer to the observational association have greater estimated
precision.100
These problems arise for IVs that are weak, but otherwise satisfy the IV assumptions. A more
further problem with weak instruments is sensitivity to violations of the IV assumptions: while
studies with stronger instruments can be insensitive to moderate violations of the IV assumptions,
studies with weak instruments are extremely sensitive to tiny violations in the assumptions.101
7.2 Comparison of methods with single instrumental variable
As previously stated, if there is a single IV, the ratio, 2SLS, LIML, GMM and SMM IV estimates
coincide. Although this IV estimate does not have a ﬁnite mean, simulations have shown that the
median bias is close to zero even when the expected F statistic is around 5.42 An F statistic of 5
corresponds to a p-value for the association of the IV with the exposure of 0.03. It is unlikely that a
variable would be used as an IV in practice unless the variable is expected to achieve a p-value of less
than 0.03 in the sample under analysis. A causal eﬀect and its direction can be assessed with a single
IV by testing for an association between the IV and outcome; this association will be a valid test of
the null hypothesis of no causal eﬀect even with a weak instrument.9 Hence, unless bias is introduced
via another mechanism (such as choosing between candidate IVs on the basis of their strength in the
data under analysis100), the problems of weak instruments should not arise with a single
instrumental variable.
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7.3 Multiple instrument variables and score-based approach
The bias of the IV estimate from the 2SLS method with a continuous outcome is approximately
1/E(F) of the bias of the observational association, where E(F) is the expected value of the F statistic
from the ﬁrst-stage regression. In contrast, the median bias of estimates from the LIML and CUE
methods is close to zero, making them useful tools for sensitivity analysis. However, in ﬁnite samples
with multiple IVs, the LIML method is generally less eﬃcient than 2SLS.98 A simulation analysis
showed that conﬁdence intervals from the LIML and CUE methods with large numbers of IVs were
much wider than those from other IV methods, despite nominal coverage levels not being
maintained83; use of Bekker standard errors to maintain nominal coverage levels resulted in
conﬁdence intervals that were wider still.
A recent innovation in Mendelian randomization is to reduce data from multiple instrumental
variables into a single univariate score, known as an allele score or genetic risk score.102 An
unweighted score is constructed as the total number of exposure-increasing alleles present in the
genotype of an individual. A weighted score can also be considered, in which each IV contributes a
weight reﬂecting the eﬀect of the corresponding genetic variant on the exposure. If an individual i
has gik copies of the exposure-increasing allele for each variant k¼ 1, . . . ,K, then their unweighted
score is zi ¼
PK
k¼1 gik. If all genetic variants are diallelic SNPs, this score takes integer values
between 0 and 2K. If the weight for variant k is wk, then their weighted score is zi ¼
PK
k¼1 wkgik:
Either score can then be used in an IV analysis.
If the weights in a weighted score are derived naively from the data under analysis, then the score-
based approach is eﬀectively a 2SLS analysis, and there is nomethodological beneﬁt of the approach to
a 2SLS analysis in terms of bias. However, if the weights are determined externally from prior
knowledge or an independent data source, or from the data under analysis by a cross-validation or
jackknife approach,103 then eﬀectively the IV analysis uses a single instrumental variable, reducing bias
to negligible levels. Additionally, when the true eﬀect sizes of the IVs do not vary greatly, score-based
approaches have been shown to give greater precision than LIML and related methods, even when the
weights for the score are misspeciﬁed or an unweighted score is used.83,102 We would therefore
recommend a score-based approach to IV analysis when there are a multiple potentially weak IVs.
A caveat is that the use of large numbers of IVs increases the possibility that one or more of
the IVs is invalid, leading to potentially misleading estimates.101 It is therefore important not
only to cite genetic associations with the outcome for the allele score but also for the constituent
genetic variants, so that the consistency of estimates across the genetic variants can be assessed.
Although allele scores can address a wide range of analysis questions in Mendelian
randomization, more complex questions (such as analyses with multiple risk factors104) cannot
be addressed using an allele score method and require the use of alternative methods.
8 Discussion
In this ﬁnal section, we discuss various practical topics relevant to IV estimation, as well as
extensions to the scenario considered in this paper of individual-level data from a single source to
estimate a linear causal eﬀect.
8.1 Non-linear relationships
With a linear exposure–outcome relationship, the estimate from a linear IV analysis, such as using
the ratio or 2SLS method, is the average change in the outcome for a uniform change (usually a 1
unit increase) in the distribution of the exposure across the population for all individuals whose
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exposure level is inﬂuenced by their value of the IV.27 For a non-linear relationship, a linear IV
estimate approximates the same population-averaged causal eﬀect when the change in the
distribution of the exposure associated with the IV is small, and when the linear IV estimate is
scaled to represent the eﬀect of a change in the exposure of similar magnitude to that associated with
a change in the IV.34
Although non-linear parametric two-stage IV methods have been proposed, inferences based on
such methods have been shown to be highly sensitive to the choice of parameterization.105,106
Equally, non-parametric two-stage IV methods have been explored,107 but evidence on the shape
of the causal relationship can only be inferred for the range of ﬁtted values for the exposure (X^WZ). A
recent development is the estimation of local IV estimates within strata of the exposure.34 However,
if the exposure is stratiﬁed on directly, misleading results may be obtained. This is because the
exposure lies on the causal pathway between the IV and the outcome, and so conditioning on the
exposure induces an association between the IV and confounders. This can be circumvented by
initially subtracting the eﬀect of the IVs on the exposure from the exposure measurement, to obtain
the ‘IV-free exposure’. This quantity, representing the expected value of the exposure for an
individual if their IVs took the value zero, can then be safely conditioned on.108 Conditioning on
this quantity is equivalent to conditioning on the residual from the ﬁrst-stage regression,65 known as
the ‘control function approach’.109 For this non-linear estimation approach to be valid, it is
necessary for the association of the IV with the exposure in the population to remain constant at
diﬀerent levels of the exposure.110
8.2 Use of measured covariates
If we can ﬁnd measured covariates which explain variation in the exposure or a continuous outcome,
then we can incorporate such covariates into our analysis. Including covariates generally increases
eﬃciency and hence the precision of the causal estimate. However, it may lead to bias in the causal
estimate if a covariate is on the causal pathway between exposure and outcome or is a collider or
causally downstream of a collider. A collider is a variable that is inﬂuenced both by the exposure or
a causal consequent thereof and by the outcome or a causal consequent thereof.111 There may also be
bias if the analysis model including the covariate is misspeciﬁed. In a two-stage estimation, any covariate
adjusted for in the ﬁrst-stage regression should also be adjusted for in the second-stage regression112;
failure to do so can cause associations between the IV and confounders leading to bias.56(p. 189)
In some cases, adjustment for covariates is necessary to ensure validity of the IVs, as the IV
assumptions only hold conditional on the covariates. An example in Mendelian randomization is the
case of population stratiﬁcation, in which the sample population consists of subpopulations that
have diﬀerent distributions of the IV and outcome.5 These subpopulations may correspond to ethnic
subgroups in the population. An association between the IV and outcome may solely correspond to
diﬀerences in ethnicity and not to any biological eﬀect of the exposure. This can be addressed at least
partially with genome-wide data, by adjusting for genetic principal components in the IV analysis,113
although there is no theoretical guarantee that adjustment for genetic principal components will
resolve the problem of population stratiﬁcation. In general, aside from these cases, we discourage
adjustment for covariates in the primary analysis result for the assessment of a causal eﬀect.
8.3 Overidentification tests
When more than one instrument is used, an overidentiﬁcation test, such as the Sargan test,114 can be
carried out to test whether the associations of the instruments with the outcome are statistically
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compatible with a single linear causal eﬀect of the exposure. Overidentiﬁcation means that the
number of instruments used is greater than the number of exposures measured. (The latter is
usually one, although analyses with multiple exposure variables have also been considered.115,116)
When there is more than one IV for a single exposure, separate causal estimates can be calculated
using each IV in turn. The overidentiﬁcation test assesses whether the parameters being estimated by
each IV separately are the same, or equivalently whether the IVs have residual associations with the
outcome once the main eﬀect of the exposure has been removed.117 Failure of an overidentiﬁcation
test indicates heterogeneity in the eﬀect estimates from each IV, which suggests that the IV
assumptions may be violated for one or more genetic variants.
Overidentiﬁcation tests are omnibus tests, where the alternative hypothesis includes failure of IV
assumptions for one IV, failure for all IVs, a non-linear association between the exposure and
outcome, and that diﬀerent IVs identify diﬀerent magnitudes of causal eﬀect.118 However, in
many practical cases they have low power,119 and so failure to reject an overidentiﬁcation test
should not be overinterpreted as positive evidence for the validity of the IV assumptions.
8.4 Endogeneity tests
Some applied Mendelian randomization analyses have reported on whether there is a diﬀerence
between the observational and IV estimates as the primary outcome of interest120; this can be
formally tested using the Durbin–Wu–Hausman test.118 This is a test of equality of the
observational and IV estimates, where a signiﬁcant result indicates disagreement between the two
estimates. It is called an endogeneity test.
While an informal comparison of the observational and causal estimates may be reasonable, for
instance to judge whether a Mendelian randomization investigation has suﬃcient power for a null
result to be informative, an endogeneity test should not be viewed as a primary analysis result. This
is because the outcome of an endogeneity test neither implies the presence nor the absence of a
causal eﬀect. It is more appropriate to consider the presence or absence of a causal eﬀect as the
subject of investigation.39 The conﬁdence interval of the causal estimate gives the researcher a sense
of the plausible size of any possible causal eﬀect based on the data available.
8.5 Power of IV analyses
The conﬁdence interval of an IV estimate is typically much wider compared with that of an
observational estimate, for example from a regression analysis. The sample size required to
obtain precise enough causal estimates to be clinically relevant can be very large.121 A rule of
thumb for power is that the sample size for a conventional analysis should be divided by the
coeﬃcient of determination (R2) of the IV on the exposure.122 Formulae for power and sample
size calculation have been published with a continuous outcome123,124 and with a binary outcome,125
and online tools for performing these calculations are available (http://glimmer.rstudio.com/kn3in/
mRnd/ and http://sb452.shinyapps.io/power/).
8.6 Summarized data
In an applied context, it may not be practical or desirable to share individual-level data on the IV,
exposure, and outcome. With a single IV, the ratio method can be implemented simply using
summarized estimates on the associations of the IV with the outcome and with the exposure.
Methods for obtaining IV estimates using summarized data on multiple IVs have been discussed
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elsewhere126: these include a likelihood-based method for the summarized association estimates, and
an inverse-variance weighted method combining the ratio estimates from each IV in a meta-analysis
model.127 A tool to implement these methods is available online (http://sb452.shinyapps.io/
summarized/).
8.7 Subsample and two-sample Mendelian randomization
Especially when the outcome is binary, the sample size required in a Mendelian randomization
experiment may be prohibitively large due to the expense of collecting data on the exposure. In
this case, a subsample IV approach may be a cost-eﬀective approach. Rather than collecting data on
the exposure from the entire study sample, exposure data can be measured for a random subsample
of (control) participants. As the association between the IV and the exposure is typically stronger
than that between the IV and the outcome, the precision of the IV estimate may not be noticeably
aﬀected by reducing the sample size on which the exposure is measured. Simulations have shown
that a subsample IV analysis with exposure data on only 10% of participants may retain 90% of the
power of the full-sample IV analysis.128 Estimates and conﬁdence intervals with a single IV can be
calculated using the ratio method and Fieller’s theorem (Section 3.4). With multiple IVs, a modiﬁed
version of the two-stage least squares method can be used.129
An alternative design is two-sample Mendelian randomization, in which the associations between
the IV(s) and the exposure and between the IV(s) and the outcome are estimated from non-
overlapping sets of individuals.130 Although this may simply reﬂect the absence of a dataset with
concomitant information on all three of the IV(s), exposure, and outcome, it is also a potentially
eﬃcient design strategy for Mendelian randomization, particularly in view of the increasing public
availability of summarized data on genetic associations with risk factors and disease outcomes from
large consortia. Several consortia with large numbers of participants, such as
CARDIoGRAMplusC4D for coronary artery disease131 and DIAGRAM for type 2 diabetes,132
have published summarized data on the association of catalogues of genetic variants with either risk
factors or disease status. These provide precise estimates of genetic associations which can be used to
obtain causal estimates, provided the genetic variants included in the analysis are restricted to those
for which the IV assumptions are valid. This makes two-sample Mendelian randomization using
summarized data a worthwhile analysis strategy from the perspective of power, and one that should
be encouraged in practice, particularly if there is available summarized data on genetic associations
with the outcome.133 The only caveat is that the two samples used should be as similar as possible
(particularly with respect to nationality/ethnicity, but also to other population characteristics). This
is because genetic variants that are valid IVs in one population may not be valid IVs in another
population, and to ensure that the magnitudes of genetic associations with the risk factor in the ﬁrst
sample are relevant estimates of the genetic associations in the second sample.
8.8 Meta-analysis
The demands of power often demand synthesis of evidence from multiple, possibly heterogeneous
studies. Data from multiple studies can be combined to provide a single causal estimate in a meta-
analysis model. If it is possible to estimate the causal eﬀect in each study, meta-analysis can be
performed directly on these estimated causal eﬀects, for example using inverse-variance
weighting.134 However, a study-level meta-analysis can accentuate weak instrument bias,100 and
so it is preferable to combine either individual-level or summarized data from each study.
Additionally, it may be that some studies only provide data on one of the exposure or the
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outcome, and so a causal eﬀect cannot be estimated from that study alone. A hierarchical model can
be therefore proposed, in which the study-speciﬁc parameters are pooled in a between-study model.
This could also be a more eﬃcient use of data if the same genetic variants were used in separate
studies. Such a model can be ﬁtted using likelihood methods on either individual-level data or
summarized data from each study.135
8.9 Robust methods
Instrumental variable estimation methods that are robust to the violation of the IV assumptions for
some or all of the ‘instruments’ have been the subject of recent methodological development. A full
exposition of these methods is beyond the scope of this manuscript, but we provide a brief overview
of some of these developments.
Given multiple candidate IVs, if over half of the ‘instruments’ satisfy the IV assumptions, then the
median of the IV estimates using each of the ‘instruments’ individually is a consistent estimate of the
causal eﬀect.136 A more eﬃcient estimator than this simple median can be constructed by a weighted
median method.137 Here, rather than assuming over 50% of the ‘instruments’ are valid IVs, we
assume that ‘instruments’ representing over 50% of the weight are valid IVs.
Alternatively, a consistent causal estimate can be obtained by allowing the ‘instruments’ to have
direct eﬀects on the outcome, but limiting the total magnitude of these direct eﬀects, for example
using L1-penalization.138 Conﬁdence intervals under the assumption that over 50% of the
‘instruments’ are valid IVs have also been developed.139 Software for performing this penalization
method is available in the R package sisVIVE.140
Finally, direct eﬀects of the IVs on the outcome can be accounted for by regressing the IV –
outcome association estimates on the IV – exposure association estimates. If the associations of IVs
with the outcome consist of a causal component, representing the eﬀect of the exposure on the
outcome, and a pleiotropic component, representing the direct eﬀect of the IV on the outcome not
via the risk factor, then the intercept from this regression model is an estimate of the average direct
eﬀect of each IV on the outcome.141 If the IV assumptions are satisﬁed, then the true direct eﬀect of
each IV on the outcome is zero. A test of whether the intercept estimate diﬀers from zero is an
assessment of the presence of directional (that is, unbalanced) pleiotropy. This is equivalent to
Egger’s test, an assessment of small sample bias (including publication bias) in meta-analysis.142,143
Under a weaker set of assumptions than the standard IV assumptions (namely that the direct
eﬀects of IVs on the outcome are distributed independently of instrument strength144), the slope
parameter from this regression with an intercept term is a consistent estimate of the causal eﬀect.
This method can be used to give a consistent estimate of the causal eﬀect even if all the ‘instruments’
are invalid, but it requires the standard untestable assumption of no direct eﬀects of the IVs on the
outcome to be replaced with another untestable (albeit weaker) assumption.
8.10 Summary
Methods for IV analysis range from the very simple to the more complicated. The development of
complex methods has been driven by the desire to produce eﬃcient estimates, for example by
integrating data on multiple IVs or multiple studies, or to provide robustness against weak
instruments or misspeciﬁcation of the modelling assumptions.
In conclusion, we emphasize that the main diﬃculty in an IV analysis is not the choice of analysis
method but rather the choice of IVs and the assessment of the IV assumptions. If the IV assumptions
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do not hold, then inferences from any analysis method will be unreliable.26 Although there are some
contexts where a particular method is unsuitable (such as with large numbers of weak instruments),
there is no single universal ‘best’ IV estimation method. Instead, the use of diﬀerent IV methods
provides sensitivity analyses to assess whether the estimate given by a particular choice of method is
credible.
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